Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Alonso, N; Wani, S; Rose, L; Van't, Hof, RJ; Ralston, SH; Albagha, OME.
Insertion Mutation in Tnfrsf11a Causes a Paget's Disease-Like Phenotype in Heterozygous Mice and Osteopetrosis in Homozygous Mice.
J Bone Miner Res. 2021; 36(7):1376-1386 Doi: 10.1002/jbmr.4288
Web of Science PubMed FullText FullText_MUG

 

Führende Autor*innen der Med Uni Graz
Alonso Lopez Nerea
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
Early onset familial Paget's disease of bone (EoPDB), familial expansile osteolysis, and expansile skeletal hyperphosphatasia are related disorders caused by insertion mutations in exon 1 of the TNFRSF11A gene, which encodes receptor activator of nuclear factor κB (RANK) protein. To understand the mechanisms underlying these disorders, we developed a mouse model carrying the 75dup27 mutation which causes EoPDB. Mice heterozygous for the mutation (Tnfrsf11a75dup27/- ) developed a PDB-like disorder with focal osteolytic lesions in the hind limbs with increasing age. Treatment of these mice with zoledronic acid completely prevented the development of lesions. Studies in vitro showed that RANK ligand (RANKL)-induced osteoclast formation and signaling was impaired in bone marrow cells from Tnfrsf11a75dup27/- animals, but that osteoclast survival was increased independent of RANKL stimulation. Surprisingly, Tnfrsf11a75dup27/75dup27 homozygotes had osteopetrosis at birth, with complete absence of osteoclasts. Bone marrow cells from these mice failed to form osteoclasts in response to RANKL and macrophage colony-stimulating factor (M-CSF) stimulation. This intriguing study has shown that in heterozygous form, the 75dup27 mutation causes focal osteolytic lesions in vivo reminiscent of the human disorder and extends osteoclast survival independently of RANKL signaling. In homozygous form, however, the mutation causes osteopetrosis due to failure of osteoclast formation and insensitivity to RANKL stimulation. © 2021 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR)..
Find related publications in this database (using NLM MeSH Indexing)
Animals - administration & dosage
Homozygote - administration & dosage
Humans - administration & dosage
Mice - administration & dosage
Mutagenesis, Insertional - administration & dosage
Mutation - administration & dosage
Osteitis Deformans - genetics
Osteoclasts - administration & dosage
Osteopetrosis - genetics
Phenotype - administration & dosage
RANK Ligand - genetics
Receptor Activator of Nuclear Factor-kappa B - genetics

Find related publications in this database (Keywords)
75dup27
MOUSE MODEL
OSTEOCLAST
PAGET&apos
S DISEASE OF BONE
RANK
© Med Uni Graz Impressum